LexDanaLexDanabeta
Inventor

Carsten Ryttersgaard

Inventor
Roskilde, DK

Overview

4→
Patents
2009–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07DHeterocyclic compounds22%
C12NMicroorganisms or enzymes22%
C12YEnzymes22%
A61KPreparations for medical, dental or toiletry purposes11%
PatentTitleYear
9,586,961'Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof'20179,346,809'Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors'20168,367,390'Galactanase variants'20137,537,921'Galactanase variants'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2013Patents assigned to NOVOZYMES AS (2)· patent assignee history
2009–2013Based in Los Angeles, CA, US· patent location history
2013–2017Patents assigned to RYTTERSGAARD CARSTEN (3)· patent assignee history
2016–2017Patents assigned to GRUE-SØRENSEN GUNNAR (2)· patent assignee history
2016–2017Patents assigned to LEO PHARMA AS (2)· patent assignee history
2016–2017Patents assigned to SCHOU SØREN CHRISTIAN (2)· patent assignee history
2016–2017Based in Roskilde, DK· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RYTTERSGAARD CARSTENself32013–2017
GRUE-SØRENSEN GUNNAR22016–2017
LEO PHARMA AS22016–2017
NOVOZYMES AS22009–2013
SCHOU SØREN CHRISTIAN22016–2017
Locations
LocationPatentsSpan
Roskilde, DK22016–2017
Los Angeles, California, US22009–2013